| Drug Name: | MALT |
| Legal Uk: | Class A |
| Legal Us: | Analogue |
| Cas Number: | 1366416-29-6 |
| Pubchem: | 155907915 |
| Chemspiderid: | 74902443 |
| Unii: | R3PSM6BEG8 |
| Synonyms: | N,N-Methylallyltyptamine; (2-(1H-Indol-3-yl)ethyl)(methyl)(prop-2-en-1-yl)amine; 1H-Indole-3-ethanamine, N-methyl-N-2-propen-1-yl-; Malt |
| Iupac Name: | N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine |
| C: | 14 |
| H: | 18 |
| N: | 2 |
| Smiles: | CN(CCC1=CNC2=CC=CC=C21)CC=C |
| Stdinchi: | 1S/C14H18N2/c1-3-9-16(2)10-8-12-11-15-14-7-5-4-6-13(12)14/h3-7,11,15H,1,8-10H2,2H3 |
| Stdinchikey: | GXCLVBGFBYZDAG-UHFFFAOYSA-N |
MALT (N-methyl-N-allyltryptamine or N,N-methylallyltryptamine) is a lesser-known drug from the tryptamine family. It is a novel compound with very little history of human use. It is closely related to methylpropyltryptamine (MPT), as well as N-methyltryptamine. It has been sold online as a designer drug. Very little information on the pharmacology or toxicity of MALT is available.
MALT is not explicitly scheduled in any countries; however, it could be considered a psychoactive substance under the UK Psychoactive Substances Act, which requires the prosecutor to prove that the substance is psychoactive in order for a person to be charged with an offense.[1]
It could also be considered a structural analog of a scheduled substance under the US Federal Analogue Act due to its similarity to scheduled tryptamines.